Dyspnea Management in Early Stage Lung Cancer: A Palliative Perspective.
Dyspnea Management in Early Stage Lung Cancer: A Palliative Perspective.
复制标题
早期肺癌的呼吸困难管理:姑息治疗的角度。
DOI:
10.1097/njh.0b013e31825e4250
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Hayter,Jennifer
中科院分区:
文献类型:
--
作者:
Williams,AnnaCathy;Grant,Marcia;Tiep,Brian;Kim,JaeY;Hayter,Jennifer
A new cohort of lung cancer patient is on the horizon. With rapidly evolving diagnostics and treatment methodology, early-stage non–small cell lung cancer patients are increasing in numbers. Although stage I-II patients are deemed “curable,” there linger threats of recurrence, new primaries, and existing or imposed comorbidities due to the treatment itself. Consequently, the outlook remains tenuous for this population. With improving survival rates, it is imperative that patients with early-stage non–small cell lung cancer be fully assessed, aggressively managed, and followed up long term, according to the National Comprehensive Cancer Network guidelines. Dyspnea is one of the most frightening of all symptoms, regardless of diagnosis and stage of any disease. It accompanies feelings of suffocating and even impending death. Given the subjectivity of dyspnea, it is critical to assess the impact it imposes on quality of life for each patient and their loved ones. Cognizant of the abundance of care involved in such cases, it is the palliative care nurse who is the core advocate and coordinator of services. Through a comprehensive care plan and interdisciplinary effort, healthcare professionals may be able to offer early-stage non–small cell lung cancer patients with dyspnea stellar evidence-based intervention and hopefully a greater chance of possessing a sense of normalcy in their lifestyles.